THEY TALK ABOUT US
Our work has been recognized by print and online publications such as
Will Immunotherapy Help Us Cure Lymphoma?
Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors
The Currently Incurable Scientist: RRx-001 and the Impact of One CRC Patient-Chemist
Leechburg woman leans on family as she battles neuroendocrine cancer
EpicentRx Announces Publication of Phase 1 Trial Results for the Anti-Cancer Agent, RRx-001, in Lancet Oncology
Reprogramming a Tumor for Death